Optogenetic construction of de novo integrin-adhesion complexes reveals role for biocondensation in adhesion nucleation

Integrin-adhesion complexes (IACs) form spontaneously in cells on extracellular matrix substrates, allowing them to sense matrix composition and transduce force. However, IACs often do not form uniformly across a cell, which begs the question: What is required to nucleate an adhesion, and what factors enable the stabilization of an IAC once it has formed? Many factors have been suggested to promote formation and the subsequent stabilization of IACs. It is difficult to explicitly test these factors in vivo as IACs undergo constant remodeling. Here, we employ optogenetics to explicitly test the ability of talin in different activity and phase states to nucleate and stabilize IACs in regions where none are present. We find that fusion of intrinsically disordered regions directly to talin enhances its adhesion nucleation potential and allows new adhesions to be produced in response to optogenetic talin clustering. Similarly, expression of factors previously shown to enhance biocondensation in vitro, such as paxillin, the paxillin N-terminus, or unfolding of talin, allows for adhesion nucleation and biocondensation of talin. We show that these biocondensates of talin can cluster and activate integrins even in the absence of extracellular matrix. By applying optogenetic activation to regions of the cell with or without ventral actomyosin, we demonstrate actomyosin engagement promotes the formation and stability of adhesions. These results are corroborated by theoretical modelling which shows that phase separation of talin is enhanced by differential clutch formation in the presence of actomyosin thus enabling peripheral adhesion formation and stability. This work establishes a model in which increased cooperativity of talin enables IAC nucleation through talin biocondensation, which clusters and activates integrins. In addition to these findings, we generate multiple optogenetic tools that enable local nucleation or enhancement of IACs.